基于钆塞酸增强MRI诊断肝细胞癌的最优词汇表:对LI-RADS的改良
回顾性分析177例肝细胞癌高危初治患者的241个肝脏病灶(149个HCC),比较改良LI-RADS词汇表(门静脉期或移行期廓清、增强或非增强包膜)与原始LI-RADS在钆塞酸增强MRI上的诊断效能。改良词汇表LR-5的敏感度和准确率显著高于原始LI-RADS,特异度无显著差异。
要点
- 改良LI-RADS词汇表将门静脉期或移行期廓清、增强或非增强包膜纳入主要征象,可提高钆塞酸增强MRI诊断HCC的敏感度。
- 改良词汇表LR-5敏感度79.2%、准确率84.6%,均显著高于原始LI-RADS的60.4%和73.9%。
- 两组特异度无显著差异(改良93.5% vs 原始95.7%,P=0.153),包膜表现的观察者间一致性为一般至中等。
核心结论
- 与原始LI-RADS相比,采用改良词汇表的LI-RADS在钆塞酸增强MRI诊断HCC时敏感度更高,特异度相似。
研究设计与样本
- 回顾性研究纳入177例有HCC风险的初治患者,共241个肝脏病灶(149个HCC、6个其他恶性肿瘤、86个良性病灶),于2013年1月至2015年12月行钆塞酸增强MRI。
- 以组织病理学或随访影像学作为参考标准,由两名委员会认证放射科医生独立评估影像特征并按原始及改良LI-RADS定义分类。
- 采用广义估计方程比较LR-5的诊断效能和观察者间一致性。
关键影像表现/征象
- 原文未报告具体影像征象描述。
诊断标准与关键数值
- 改良定义包括:廓清表现定义为门静脉期或移行期出现(对比原始仅门静脉期),包膜定义为增强或非增强包膜(对比原始仅增强包膜)。
- 改良词汇表LR-5敏感度79.2%(95%CI 71.9–85.0),准确率84.6%(79.5–88.7),特异度93.5%(86.2–97.0)。
- 原始LI-RADS LR-5敏感度60.4%(52.3–67.9),准确率73.9%(67.9–79.0),特异度95.7%(89.0–98.4);敏感度和准确率比较P<0.001,特异度比较P=0.153。
- 病灶<2 cm或≥2 cm亚组显示相似趋势。
临床应用与阅片要点
- 原文未据此给出具体阅片建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To define the optimal lexicon of major imaging findings on gadoxetic acid-enhanced MRIs to diagnose HCC to improve diagnostic performance of the LI-RADS.
METHODS: Two hundred forty-one hepatic lesions (149 HCC, six other malignancies, 86 benign lesions) in 177 treatment-naïve patients at risk of HCC who underwent gadoxetic acid-MRIs from January 2013 to December 2015 were retrospectively reviewed using either histopathological or follow-up imaging findings as a standard reference. Two board-certified radiologists independently evaluated the imaging features and categorized the nodules based on the original and the following modified definitions in LI-RADS: (1) washout appearance in the portal venous phase (PVP) only versus that in the PVP or transitional phase, and (2) enhancing capsule only versus enhancing or non-enhancing capsule. Diagnostic performance and inter-observer agreement of LR-5 were assessed and compared between the algorithms using generalized estimation equation.
RESULTS: The sensitivity [79.2% (95% confidence interval 71.9, 85.0)] and accuracy [84.6% (79.5, 88.7)] of LR-5 were significantly higher for modified lexicon compared with original LI-RADS [60.4% (52.3, 67.9) and 73.9% (67.9, 79.0); P < 0.001 in all cases]. There was no significant difference in specificity [93.5% (86.2, 97.0) and 95.7% (89.0, 98.4); P = 0.153]. Subgroups of lesions < or ≥ 2 cm showed similar tendencies. Inter-observer agreement for capsule appearance was fair to moderate, whereas that for other imaging findings was good to excellent.
CONCLUSIONS: Compared to original LI-RADS, LI-RADS with modified lexicon showed higher sensitivity for the diagnosis of HCC using gadoxetic acid-MRI, with similar specificity.
引用
- Hwang SH, Park S, Han K, et al. Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS. Abdom Radiol (NY). 2019. PMID: 31165907. doi:10.1007/s00261-019-02077-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。